Macro Finance
GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue
Bloomberg Markets·October 30, 2026·1 min read
Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity. The trend reflects a broader global boom in weight-loss and diabetes treatments.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.